Reuters logo
BRIEF-Divi's Labs says co takes steps to meet FDA's compliance needs after import alert on Visakhapatnam plant
March 22, 2017 / 11:22 AM / 9 months ago

BRIEF-Divi's Labs says co takes steps to meet FDA's compliance needs after import alert on Visakhapatnam plant

March 22 (Reuters) - Divi’s Laboratories Ltd

* FDA import alert for products manufactured at co’s unit-II at Visakhapatnam was issued under 2 clauses 66-40 & 99-32 of FDA regulations

* Says company has already initiated necessary measures to address concerns raised by US-FDA

* Says co is making all efforts to fully meet compliance requirements Source text: bit.ly/2o45LNK Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below